FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ingeborg Walter-Sack

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Disorders

Falciparum Malaria

Geographic Areas

Burkina Faso

Co-author Network

Publications

TOP 3
Olaf Müller; R Heiner Schirmer; Ali Sié; Ingeborg Walter-Sack; Hannes Buchner; Boubacar Coulibaly; Ronny Kuhnert; Bernd Marks; Peter Meissner; Frank P Mockenhaupt; Ulrich Mansmann
Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs.
Florentine Carow; Hans H Maurer; Markus R Meyer; Frank T Peters; Karin Rieger; Ingeborg Walter-Sack; Walter E Haefeli
Objective assessment of nonadherence and unknown co-medication in hospitalized patients.
H M Seidling; S P W Schmitt; T Bruckner; J Kaltschmidt; Markus Pruszydlo; C Senger; Thilo Bertsche; Ingeborg Walter-Sack; Walter E Haefeli
Patient-specific electronic decision support reduces prescription of excessive doses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ingeborg Walter-Sack (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Olaf Müller; R Heiner Schirmer; Ali Sié; Ingeborg Walter-Sack; Hannes Buchner; Boubacar Coulibaly; Ronny Kuhnert; Bernd Marks; Peter Meissner; Frank P Mockenhaupt; Ulrich Mansmann
Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs.
Pharmacoepidemiology and drug safety 2013;22(4):376-85.
2012: Florentine Carow; Hans H Maurer; Markus R Meyer; Frank T Peters; Karin Rieger; Ingeborg Walter-Sack; Walter E Haefeli
Objective assessment of nonadherence and unknown co-medication in hospitalized patients.
European journal of clinical pharmacology 2012;68(8):1191-9.
2010: H M Seidling; S P W Schmitt; T Bruckner; J Kaltschmidt; Markus Pruszydlo; C Senger; Thilo Bertsche; Ingeborg Walter-Sack; Walter E Haefeli
Patient-specific electronic decision support reduces prescription of excessive doses.
Quality & safety in health care 2010;19(5):e15.
2010: Mamadou Bountogo; Augustin Zoungrana; Boubacar Coulibaly; Christina Klose; Ulrich Mansmann; Frank P Mockenhaupt; Jürgen Burhenne; Gerd Mikus; Ingeborg Walter-Sack; R Heiner Schirmer; Ali Sié; Peter E Meissner; Olaf Müller
Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso.
Tropical medicine & international health : TM & IH 2010;15(6):713-7.
2010: Thilo Bertsche; Johannes Pfaff; Petra Schiller; Jens Kaltschmidt; Markus G Pruszydlo; Wolfgang Stremmel; Ingeborg Walter-Sack; Walter E Haefeli; Jens Encke
Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system.
Intensive care medicine 2010;36(4):665-72.
2009: Hanna Marita Seidling; Caroline Henrike Storch; Thilo Bertsche; Christian Senger; Jens Kaltschmidt; Ingeborg Walter-Sack; Walter E Haefeli
Successful strategy to improve the specificity of electronic statin-drug interaction alerts.
European journal of clinical pharmacology 2009;65(11):1149-57.
2009: Johanna Weiss; Magdalena Maria Ten Hoevel; Jürgen Burhenne; Ingeborg Walter-Sack; Michael M Hoffmann; Jens Rengelshausen; Walter E Haefeli; Gerd Mikus
CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.
Journal of clinical pharmacology 2009;49(2):196-204.
2009: Ingeborg Walter-Sack; Jens Rengelshausen; Heike Oberwittler; Jürgen Burhenne; Olaf Mueller; Peter Meissner; Gerd Mikus
High absolute bioavailability of methylene blue given as an aqueous oral formulation.
European journal of clinical pharmacology 2009;65(2):179-89.
2008: Walter E Haefeli; Ingeborg Walter-Sack
[Particularities of drug dosing at the beginning and end of therapy].
Therapeutische Umschau. Revue thérapeutique 2008;65(10):573-5.
2008: Tilman Heinrich; Hartmut Heidt; Verena Hafner; Heinrich Schmidt-Gayk; Ekkehart Jenetzky; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Bommer
Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(9):2861-7.
2008: Felix Gut; Wolfgang Schiek; Walter E Haefeli; Ingeborg Walter-Sack; Jürgen Burhenne
Cation exchange resins as pharmaceutical carriers for methylene blue: binding and release.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;69(2):582-7.
2008: Thorsten Steiner; Ingeborg Walter-Sack; J Taupitz; Werner Hacke; T Strowitzki
[Ethical and legal aspects of including patients unable to consent in acute therapy studies. Example of a medication study for the treatment of intracerebral hemorrhage--the Heidelberg procedure].
Deutsche medizinische Wochenschrift (1946) 2008;133(15):787-92.
2008: V Hafner; C Rutsch; R Ding; T Heinrich; L Diedrichs; H Schmidt-Gayk; Ingeborg Walter-Sack; J Bommer; Gerd Mikus
Calcium balance during calcitriol and paricalcitol administration in healthy humans.
International journal of clinical pharmacology and therapeutics 2008;46(3):131-5.
2008: Jürgen Burhenne; Klaus-Dieter Riedel; Jens Rengelshausen; Peter E Meissner; Olaf Müller; Gerd Mikus; Walter E Haefeli; Ingeborg Walter-Sack
Quantification of cationic anti-malaria agent methylene blue in different human biological matrices using cation exchange chromatography coupled to tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;863(2):273-82.
2008: Augustin Zoungrana; Boubacar Coulibaly; Ali Sié; Ingeborg Walter-Sack; Frank P Mockenhaupt; Bocar Kouyaté; R Heiner Schirmer; Christina Klose; Ulrich Mansmann; Peter E Meissner; Olaf Müller
Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
PloS one 2008;3(2):e1630.
2008: Peter E Meissner; Germain Mandi; Frank P Mockenhaupt; Steffen Witte; Boubacar Coulibaly; Ulrich Mansmann; Claudia Frey; Heiko Merkle; Jürgen Burhenne; Ingeborg Walter-Sack; Olaf Müller
Marked differences in the prevalence of chloroquine resistance between urban and rural communities in Burkina Faso.
Acta tropica 2008;105(1):81-6.
2007: Jens Rengelshausen; Christoph Göggelmann; Jürgen Burhenne; Klaus-Dieter Riedel; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid.
International journal of clinical pharmacology and therapeutics 2007;45(8):431-7.
2006: Jens Rengelshausen; Bernd Beedgen; Konstantina Tsamouranis; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli; Otwin Linderkamp
Pharmacokinetics of a netilmicin loading dose on the first postnatal day in preterm neonates with very low gestational age.
European journal of clinical pharmacology 2006;62(9):773-7.
2006: Thilo Bertsche; Reiner Fritz; Peter Sauer; Jens Encke; Walter E Haefeli; Ingeborg Walter-Sack
[Off label use in long-term anticoagulation after liver transplantation due to phenprocoumon-induced hepatic failure].
Medizinische Monatsschrift für Pharmazeuten 2006;29(7):257-62.
2006: Thilo Bertsche; M Haas; H Oberwittler; Walter E Haefeli; Ingeborg Walter-Sack
[Drugs during pregnancy and breastfeeding: new risk categories--antibiotics as a model].
Deutsche medizinische Wochenschrift (1946) 2006;131(18):1016-22.
2006: Raoul Bergner; Martin Hoffmann; Klaus-Dieter Riedel; Gerd Mikus; Dirk M Henrich; Walter E Haefeli; Michael Uppenkamp; Ingeborg Walter-Sack
Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(4):1019-23.
2006: Peter E Meissner; Germain Mandi; Boubacar Coulibaly; Steffen Witte; Théophile Tapsoba; Ulrich Mansmann; Jens Rengelshausen; Wolfgang Schiek; Albrecht Jahn; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Burhenne; Klaus-Dieter Riedel; R Heiner Schirmer; Bocar Kouyaté; Olaf Müller
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine.
Malaria journal 2006;5():84.
2005: Thilo Bertsche; Reiner Fritz; Peter Sauer; Jens Encke; Walter E Haefeli; Ingeborg Walter-Sack
[Off-label use in long-term anticoagulation after liver transplantation due to phenprocoumon-induced hepatic failure].
Medizinische Klinik (Munich, Germany : 1983) 2005;100(12):820-4.
2005: Jens Rengelshausen; Maria Banfield; Klaus-Dieter Riedel; Jürgen Burhenne; Johanna Weiss; Torben Thomsen; Ingeborg Walter-Sack; Walter E Haefeli; Gerd Mikus
Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics.
Clinical pharmacology and therapeutics 2005;78(1):25-33.
2005: Wolfgang Gröbner; Ingeborg Walter-Sack
[Treatment of hyperuricemia and gout].
Medizinische Monatsschrift für Pharmazeuten 2005;28(5):159-64; quiz 165-6.
2005: Peter E Meissner; Germain Mandi; Steffen Witte; Boubacar Coulibaly; Ulrich Mansmann; Jens Rengelshausen; Wolfgang Schiek; Albrecht Jahn; Mamadou Sanon; Théophile Tapsoba; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Burhenne; Klaus-Dieter Riedel; Heiner Schirmer; Bocar Kouyaté; Olaf Müller
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].
Malaria journal 2005;4():45.
2005: Germain Mandi; Steffen Witte; Peter E Meissner; Boubacar Coulibaly; Ulrich Mansmann; Jens Rengelshausen; Wolfgang Schiek; Albrecht Jahn; Mamadou Sanon; Kirsten Wüst; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Burhenne; Klaus-Dieter Riedel; Heiner Schirmer; Bocar Kouyaté; Olaf Müller
Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.
Tropical medicine & international health : TM & IH 2005;10(1):32-8.
2004: Margit Fröhlich; Nadine Albermann; Alexandra Sauer; Ingeborg Walter-Sack; Walter E Haefeli; Johanna Weiss
In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins.
Biochemical pharmacology 2004;68(12):2409-16.
2004: Jens Rengelshausen; Jürgen Burhenne; Margit Fröhlich; Yorki Tayrouz; Shio Kumar Singh; Klaus-Dieter Riedel; Olaf Müller; Torsten Hoppe-Tichy; Walter E Haefeli; Gerd Mikus; Ingeborg Walter-Sack
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria.
European journal of clinical pharmacology 2004;60(10):709-15.
2004: Meret Martin-Facklam; Karin Rieger; Klaus-Dieter Riedel; Jürgen Burhenne; Ingeborg Walter-Sack; Walter E Haefeli
Undeclared exposure to St. John's Wort in hospitalized patients.
British journal of clinical pharmacology 2004;58(4):437-41.
2004: Jens Rengelshausen; Heike Lindenmaier; Tomas Cihlar; Ingeborg Walter-Sack; Walter E Haefeli; Johanna Weiss
Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine.
Biochemical and biophysical research communications 2004;320(1):90-4.
2004: Karin Rieger; André Scholer; Isabelle Arnet; Frank T Peters; Hans H Maurer; Ingeborg Walter-Sack; Walter E Haefeli; Meret Martin-Facklam
High prevalence of unknown co-medication in hospitalised patients.
European journal of clinical pharmacology 2004;60(5):363-8.
2004: Margit Fröhlich; Jürgen Burhenne; Meret Martin-Facklam; Johanna Weiss; Michael Von Wolff; Thomas Strowitzki; Ingeborg Walter-Sack; Walter E Haefeli
Oral contraception does not alter single dose saquinavir pharmacokinetics in women.
British journal of clinical pharmacology 2004;57(3):244-52.
2004: Ingeborg Walter-Sack; Christof Clanget; Reinhard Ding; Christoph Goeggelmann; Vera Hinke; Matthias Lang; Johannes Pfeilschifter; Yorki Tayrouz; Karl Wegscheider
Assessment of levothyroxine sodium bioavailability: recommendations for an improved methodology based on the pooled analysis of eight identically designed trials with 396 drug exposures.
Clinical pharmacokinetics 2004;43(14):1037-53.
2003: Jens Rengelshausen; Christoph Göggelmann; Jürgen Burhenne; Klaus-Dieter Riedel; Jochen Ludwig; Johanna Weiss; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
British journal of clinical pharmacology 2003;56(1):32-8.
2002: Meret Martin-Facklam; Jürgen Burhenne; Reinhard Ding; Ruth Fricker; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL.
British journal of clinical pharmacology 2002;53(6):576-81.
2002: Ingeborg Walter-Sack; Walter E Haefeli
[Framework for biomedical research involving human subjects - algorithms for planning and organisation].
Deutsche medizinische Wochenschrift (1946) 2002;127(12):627-33.
2002: Jens Rengelshausen; William E Hull; Vedat Schwenger; Christoph Göggelmann; Ingeborg Walter-Sack; Jürgen Bommer
Pharmacokinetics of 5-fluorouracil and its catabolites determined by 19F nuclear magnetic resonance spectroscopy for a patient on chronic hemodialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(2):E10.
2002: Wolfgang Gröbner; Ingeborg Walter-Sack
[Hyperuricemia and gout--treatment].
Deutsche medizinische Wochenschrift (1946) 2002;127(5):210-3.
2002: Wolfgang Gröbner; Ingeborg Walter-Sack
[Hyperuricemia and gout--diagnosis].
Deutsche medizinische Wochenschrift (1946) 2002;127(5):207-9.
2002: Wolfgang Gröbner; Ingeborg Walter-Sack
[Hyperuricemia and gout. Case report].
Deutsche medizinische Wochenschrift (1946) 2002;127(5):207-9.
2000: Stefan Schwarz; Michael Knauth; Stefan Schwab; Ingeborg Walter-Sack; Eckhard Bonmann; Brigitte Storch-Hagenlocher
Acute disseminated encephalomyelitis after parenteral therapy with herbal extracts: a report of two cases.
Journal of neurology, neurosurgery, and psychiatry 2000;69(4):516-8.
2000: M Schwaninger; P Ringleb; A Annecke; R Winter; Brigitte Kohl; Egon Werle; Walter Fiehn; P A Rieser; Ingeborg Walter-Sack
Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patients.
Journal of neurology 2000;247(9):687-90.
2000: P B Salbach; M Brückmann; O Turovets; J Kreuzer; W Kübler; Ingeborg Walter-Sack
Heparin-mediated selective release of hepatocyte growth factor in humans.
British journal of clinical pharmacology 2000;50(3):221-6.
1999: M Schwaninger; P Ringleb; R Winter; Brigitte Kohl; Walter Fiehn; P A Rieser; Ingeborg Walter-Sack
Elevated plasma concentrations of homocysteine in antiepileptic drug treatment.
Epilepsia 1999;40(3):345-50.
1998: Wolfgang Gröbner; Ingeborg Walter-Sack; JX de Vries
Disease-specific noncompliance with drug treatment as a cause of persistent hyperuricemia and gout in anorexia nervosa.
European journal of medical research 1998;3(1-2):77-80.
1998: Ingeborg Walter-Sack; JX de Vries; A Ittensohn; R Raedsch
Biliary excretion of benzbromarone and its hydroxilated main metabolites in humans.
European journal of medical research 1998;3(1-2):45-9.
1998: J Wacker; P Werner; Ingeborg Walter-Sack; Gunther Bastert
Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(2):318-25.
1998: Cristoph Wandel; R H Böcker; H Böhrer; J X deVries; W Hofmann; K Walter; B Kleingeist; S Neff; R Ding; Ingeborg Walter-Sack; E Martin
Relationship between hepatic cytochrome P450 3A content and activity and the disposition of midazolam administered orally.
Drug metabolism and disposition: the biological fate of chemicals 1998;26(2):110-4.
1998: C Bommer; Egon Werle; Ingeborg Walter-Sack; C Keller; F Gehlen; C Wanner; M Nauck; Winfried März; Heinrich Wieland; Jürgen Bommer
D-thyroxine reduces lipoprotein(a) serum concentration in dialysis patients.
Journal of the American Society of Nephrology : JASN 1998;9(1):90-6.
1997: C Marburger; D Maclachian; O Haisken; J X deVries; Ingeborg Walter-Sack; Konrad Andrassy; Peter Nawroth; Reinhard Ziegler; H Kather
[Secondary resistance to coumarin derivatives in a patient with a hypercoagulability syndrome].
Deutsche medizinische Wochenschrift (1946) 1997;122(31-32):959-64.
1997: D Siemon; JX de Vries; F Stötzer; Ingeborg Walter-Sack; R Dietl
Fasting and postprandial disposition of R(-)- and S(+)-ibuprofen following oral administration of racemic drug in healthy individuals.
European journal of medical research 1997;2(5):215-9.
1996: Ingeborg Walter-Sack; J X de Vries; B Ernst; M Frei; S Kolb; J Kosmowski; U Priebe; H E Schroder; C Slotty; A Voss; A Weber; K Wegscheider
Uric acid lowering effect of oxipurinol sodium in hyperuricemic patients - therapeutic equivalence to allopurinol.
The Journal of rheumatology 1996;23(3):498-501.
1995: Ingeborg Walter-Sack; J X de Vries; A von Bubnoff; V Pfleilschifter; R Raedsch
Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
European journal of medical research 1995;1(1):16-20.
1995: Ingeborg Walter-Sack; J X de Vries; C Kutschker; A Ittensohn; A Voss
Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals.
European journal of clinical pharmacology 1995;49(3):215-20.
1994: J X de Vries; A Voss; A Ittensohn; Ingeborg Walter-Sack; W Löffler; R Landthaler; N Zöllner
Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. II. Kinetics of allopurinol, oxipurinol, and hydrochlorothiazide.
The Clinical investigator 1994;72(12):1076-81.
1994: W Löffler; R Landthaler; J X de Vries; Ingeborg Walter-Sack; A Ittensohn; A Voss; N Zöllner
Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. I. Uric acid kinetics.
The Clinical investigator 1994;72(12):1071-5.
1994: Jochen Rudi; R Raedsch; C Gerteis; T Schlenker; J Plachky; Ingeborg Walter-Sack; A Sabouraud; J M Scherrmann; B Kommerell
Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment.
Scandinavian journal of gastroenterology 1994;29(4):346-51.
1993: T Schlenker; R Raedsch; J X DeVries; E Schmitz-Kummer; Ingeborg Walter-Sack; E M Rothe; B Kommerell
Self-medication for abdominal discomfort resulting in life-threatening consequences.
The Clinical investigator 1993;72(1):74-5.
1993: J X De Vries; Ingeborg Walter-Sack; A Voss; W Forster; P Ilisistegui Pons; F Stoetzer; M Spraul; M Ackermann; G Moyna
Metabolism of benzbromarone in man: structures of new oxidative metabolites, 6-hydroxy- and 1'-oxo-benzbromarone, and the enantioselective formation and elimination of 1'-hydroxybenzbromarone.
Xenobiotica; the fate of foreign compounds in biological systems 1993;23(12):1435-50.
1993: J X de Vries; Ingeborg Walter-Sack; A Ittensohn; E Weber; H Empl; Ursula Gresser; N Zöllner
Benzbromarone hydroxylation in man: defective formation of the 6-hydroxybenzbromarone metabolite.
The Clinical investigator 1993;71(11):947-52.
1993: Ingeborg Walter-Sack; J X de Vries; C Kreiner; A Ittensohn; G Stenzhorn; A Voss; E Weber
Bioequivalence of allopurinol preparations: to be assessed by the parent drug or the active metabolite?
The Clinical investigator 1993;71(3):240-6.
1993: J X de Vries; M Simon; U Völker; Ingeborg Walter-Sack; E Weber; K Stegmeier
Comparative plasma disposition and anticoagulant activities of racemic phenprocoumon and its metabolites in rats.
Haemostasis 1993;23(1):13-8.
1992: Ingeborg Walter-Sack; J X de Vries; Jochen Rudi; R Conradi; Martin Kohlmeier; Brigitte Kohl; E Weber
Lack of accumulation of midazolam in plasma and lipoprotein fractions during intravenous lipid infusions in patients on artificial respiration.
European journal of clinical pharmacology 1992;42(1):71-5.
1992: Ingeborg Walter-Sack
What is "fasting" drug administration? On the role of gastric motility in drug absorption.
European journal of clinical pharmacology 1992;42(1):11-3.
1991: Ingeborg Walter-Sack
[Food intake and resorption of drugs from the gastrointestinal tract].
Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete 1991;46(4):95-100.
1990: N Zöllner; Ursula Gresser; Ingeborg Walter-Sack
Deficient benzbromarone elimination: a familial disorder?
Klinische Wochenschrift 1990;68(2):101.
1990: J X de Vries; Jochen Rudi; Ingeborg Walter-Sack; R Conradi
The determination of total and unbound midazolam in human plasma. A comparison of high performance liquid chromatography, gas chromatography and gas chromatography/mass spectrometry.
Biomedical chromatography : BMC 1990;4(1):28-33.
1990: Ingeborg Walter-Sack; Ursula Gresser; M Adjan; I Kamilli; A Ittensohn; J X de Vries; E Weber; N Zöllner
Variation of benzbromarone elimination in man--a population study.
European journal of clinical pharmacology 1990;39(2):173-6.
1990: Ingeborg Walter-Sack; J X de Vries; A Ittensohn; E Weber
Rapid and slow benzbromarone elimination phenotypes in man: benzbromarone and metabolite profiles.
European journal of clinical pharmacology 1990;39(6):577-81.
1989: J X De Vries; Ingeborg Walter-Sack; A Ittensohn; E Weber
The isolation, identification and structure of a new hydroxylated metabolite of benzbromarone in man.
Xenobiotica; the fate of foreign compounds in biological systems 1989;19(12):1461-70.
1989: Ingeborg Walter-Sack; J X de Vries; B Nickel; G Stenzhorn; E Weber
The influence of different formula diets and different pharmaceutical formulations on the systemic availability of paracetamol, gallbladder size, and plasma glucose.
International journal of clinical pharmacology, therapy, and toxicology 1989;27(11):544-50.
1988: Ingeborg Walter-Sack; M Eichelbaum; J X de Vries; E Weber
Benzbromarone biotransformation is not related to polymorphic oxidation of sparteine.
Klinische Wochenschrift 1988;66(21):1097-8.
1988: Ingeborg Walter-Sack; J X de Vries; A Ittensohn; Martin Kohlmeier; E Weber
Benzbromarone disposition and uricosuric action; evidence for hydroxilation instead of debromination to benzarone.
Klinische Wochenschrift 1988;66(4):160-6.
1988: J X de Vries; R Raedsch; U Völker; Ingeborg Walter-Sack; E Weber
Biliary excretion of phenprocoumon and metabolites.
European journal of clinical pharmacology 1988;35(4):433-6.
1987: Ingeborg Walter-Sack
Recommendations for controlling the effects of nutrition during assessment of the systemic availability of drugs.
Klinische Wochenschrift 1987;65(22):1109-12.
1987: Ingeborg Walter-Sack
The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion.
Klinische Wochenschrift 1987;65(21):1062-72.
1987: Ingeborg Walter-Sack
The influence of nutrition on the systemic availability of drugs. Part I: Drug absorption.
Klinische Wochenschrift 1987;65(19):927-35.
1987: J X de Vries; Ingeborg Walter-Sack; A Ittensohn
Analysis of benzbromarone in human plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.
Journal of chromatography 1987;417(2):420-7.
1987: E Weber; T Jacubeit; A Auwärter; R Ding; F Gutzler; K Mörike; Ingeborg Walter-Sack
Clinical and practitioners' reports on adverse effects of co-trimoxazole.
Infection 1987;15 Suppl 5():S241-7.
1986: J X de Vries; Ingeborg Walter-Sack; A van de Loo; J Kocher
Determination of benzarone in human plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry. Identification of the conjugates.
Journal of chromatography 1986;382():167-74.
1980: Ingeborg Walter-Sack; W Gröbner
[24 years of periodic fever].
MMW, Münchener medizinische Wochenschrift 1980;122(48):1729-30.